BioCentury | Jun 23, 2020
Deals

Vaccines deal with Sanofi to propel Translate Bio’s mRNA therapeutics platform

...to accelerate the company’s clinical development timelines and expand its internal pipeline. After launching as RaNA Therapeutics Inc....
BioCentury | Aug 17, 2018
Targets & Mechanisms

RNA party

...to have differentiated 3-D RNA structures. Translate Bio was founded in 2011 under the name RaNA Therapeutics Inc....
BioCentury | Jun 29, 2018
Financial News

Tricida, Translate Bio, Forty Seven and Entera price IPOs

...million. It had aimed to sell 7.7 million shares at $12-$14. Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Jun 28, 2018
Financial News

Tricida gains, others dip after upsized IPOs

...million. It had aimed to sell 7.7 million shares at $12-$14. Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Jun 15, 2018
Company News

Sanofi, Translate in mRNA vaccines deal

...BioNTech AG (Mainz, Germany) to discover and develop mRNA-based cancer immunotherapies. Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Jun 11, 2018
Company News

Sanofi, Translate in mRNA vaccines deal

...and develop mRNA-based cancer immunotherapies (see BioCentury, Feb. 24, 2017) . Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Nov 6, 2017
Company News

Management tracks: Anthem, Aimmune

...area head at Bristol-Myers Squibb Co. (NYSE:BMY). Genetic disease company Translate Bio (Cambridge, Mass.), formerly RaNA Therapeutics Inc....
BioCentury | Aug 10, 2017
Preclinical News

CRISPR activation screen can identify functional lncRNAs

...involved in a variety of diseases. Jeannie Lee at Harvard Medical School and co-founder of RaNA Therapeutics Inc....
...of the non-coding genome in development and disease. Mary Romeo Zelboraf Broad Institute of MIT and Harvard Harvard Medical School RaNA Therapeutics Inc. Translate...
BioCentury | Jul 5, 2017
Company News

Management tracks

...development officer at Nuritas Ltd. (Dublin, Ireland). Genetic disease company Translate Bio (Cambridge, Mass.), formerly RaNA Therapeutics Inc....
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...investments.” Notable platform investments by the fund include Padlock Therapeutics Inc. and RNA therapeutics company RaNA Therapeutics Inc....
...NYSE:NVO), Bagsvaerd, Denmark Petra Pharma Corp., New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. RaNA Therapeutics Inc....
Items per page:
1 - 10 of 44
BioCentury | Jun 23, 2020
Deals

Vaccines deal with Sanofi to propel Translate Bio’s mRNA therapeutics platform

...to accelerate the company’s clinical development timelines and expand its internal pipeline. After launching as RaNA Therapeutics Inc....
BioCentury | Aug 17, 2018
Targets & Mechanisms

RNA party

...to have differentiated 3-D RNA structures. Translate Bio was founded in 2011 under the name RaNA Therapeutics Inc....
BioCentury | Jun 29, 2018
Financial News

Tricida, Translate Bio, Forty Seven and Entera price IPOs

...million. It had aimed to sell 7.7 million shares at $12-$14. Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Jun 28, 2018
Financial News

Tricida gains, others dip after upsized IPOs

...million. It had aimed to sell 7.7 million shares at $12-$14. Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Jun 15, 2018
Company News

Sanofi, Translate in mRNA vaccines deal

...BioNTech AG (Mainz, Germany) to discover and develop mRNA-based cancer immunotherapies. Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Jun 11, 2018
Company News

Sanofi, Translate in mRNA vaccines deal

...and develop mRNA-based cancer immunotherapies (see BioCentury, Feb. 24, 2017) . Founded in 2011 as RaNa Therapeutics Inc....
BioCentury | Nov 6, 2017
Company News

Management tracks: Anthem, Aimmune

...area head at Bristol-Myers Squibb Co. (NYSE:BMY). Genetic disease company Translate Bio (Cambridge, Mass.), formerly RaNA Therapeutics Inc....
BioCentury | Aug 10, 2017
Preclinical News

CRISPR activation screen can identify functional lncRNAs

...involved in a variety of diseases. Jeannie Lee at Harvard Medical School and co-founder of RaNA Therapeutics Inc....
...of the non-coding genome in development and disease. Mary Romeo Zelboraf Broad Institute of MIT and Harvard Harvard Medical School RaNA Therapeutics Inc. Translate...
BioCentury | Jul 5, 2017
Company News

Management tracks

...development officer at Nuritas Ltd. (Dublin, Ireland). Genetic disease company Translate Bio (Cambridge, Mass.), formerly RaNA Therapeutics Inc....
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...investments.” Notable platform investments by the fund include Padlock Therapeutics Inc. and RNA therapeutics company RaNA Therapeutics Inc....
...NYSE:NVO), Bagsvaerd, Denmark Petra Pharma Corp., New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. RaNA Therapeutics Inc....
Items per page:
1 - 10 of 44